Oliver Wyman research highlights key treatment decision and prevalence of avoidable care.
Why is the shift to value taking so long? And where are the promised results? There's nothing wrong with the model; the problem is in execution and implementation.
Understanding clinical variation is key to identifying inappropriate care; addressing inappropriate care is key to reducing costs and improving quality.
As provider organizations prepare for MACRA, they should consider these five workforce and organizational issues.
A comprehensive view of the ACO market, including a detailed look at “winners”, regional differences, and success rates by type.
Oliver Wyman analysis details the performance of ACOs by type (physician-led, hospital-led, commercial) and offers insight into what it will take for each to be successful.
Although the details and timing of repeal-and-replace are as yet unknown, providers can still begin preparing for change.
Why the path to value remains necessary to offset the high-cost/low-quality formula – no matter who is sitting in the White House.
Oliver Wyman's Chief Medical Officer breaks down how healthcare providers may be impacted by an ACA repeal.
Our Chief Medical Officer Dr. Bruce Hamory charts the progress of federal value-based initiatives, pilots, and targets.